SYQUANT CAPITAL SAS

Position in ABVX — Abivax S.A.

CIK 1766392 PARIS, I0

Position in ABVX

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$5,263,770

+$531,395 QoQ

Shares Held

39,500

-7.1% QoQ

Ownership

0.045%

of shares outstanding

% of Portfolio

1.29%

of 13F equity value

Holder Rank

of 17 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

SYQUANT CAPITAL SAS holds $13,916,670 across 3 Biotechnology names. ABVX ranks #1 (37.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A. This page	39,500	$5,263,770
2	OCS	Oculis Holding AG	375,000	$5,201,250
3	IVA	Inventiva S.A.	913,135	$3,451,650

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,263,770	39,500	-7.1%	Shares	Sole	2026-07-09
2026-03-31	$4,732,375	42,500	—	Shares	Sole	2026-04-10
No filing history on record for this holder in this stock.